The Immunogenicity of Monovalent Oral Poliovirus Vaccine Type 1 (mOPV1) and Inactivated Poliovirus Vaccine (IPV) in the EPI Schedule of India

Background: In 2016, the Global Polio Eradication Initiative (GPEI) recommended the cessation of using type 2 oral poliovirus vaccine (OPV) and OPV, with countries having to switch from the trivalent to bivalent OPV (bOPV) with the addition of inactivated poliovirus vaccine (IPV) in their routine im...

Повний опис

Збережено в:

Бібліографічні деталі
Автори:	Lalitendu Mohanty, T. Jacob John, Shailesh D. Pawar, Padmasani Venkat Ramanan, Sharad Agarkhedkar, Pradeep Haldar
Формат:	Artigo
Мова:	Inglês
Опубліковано:	MDPI AG 2024-04-01
Серія:	Vaccines
Предмети:	poliomyelitis bivalent oral poliovirus vaccine monovalent oral type 2 poliovirus vaccine inactivated poliovirus vaccine routine immunization India
Онлайн доступ:	https://www.mdpi.com/2076-393X/12/4/424
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!

The Immunogenicity of Monovalent Oral Poliovirus Vaccine Type 1 (mOPV1) and Inactivated Poliovirus Vaccine (IPV) in the EPI Schedule of India

Схожі ресурси